doc. Mgr. Kamil Paruch, Ph.D.

2022

• Characterization of an RNA binding protein interactome reveals a context-specific post-transcriptional landscape of MYC-amplified medulloblastoma

  KAMEDA-SMITH Michelle M. M. ZHU Helen LUO En-Ching SUK Yujin XELLA Agata YEE Brian CHOKSHI Chirayu XING Sansi TAN Frederick FOX Raymond G. G. ADILE Ashley A. A. BAKHSHINYAN David BROWN Kevin GWYNNE William D. D. SUBAPANDITHA Minomi MILETIC Petar PICARD Daniel BURNS Ian MOFFAT Jason PARUCH Kamil FLEMING Adam HOPE Kristin PROVIAS John P P REMKE Marc LU Yu REYA Tannishtha VENUGOPAL Chitra REIMAND Juri WECHSLER-REYA Robert J J YEO Gene W W SINGH Sheila K K

  Article in Periodical

  Nature Communications, year: 2022, volume: 13, edition: 1, DOI

• Inhibitory kinázy Haspin

  PARUCH Kamil

  Outcomes put into operation (prototype, working sample)

  Year: 2022

• Substituted aminothiazoles as inhibitors of nucleases

  PARUCH Kamil CARBAIN Benoit Jean-Pierre HAVEL Štěpán DAMBORSKÝ Jiří BREZOVSKÝ Jan DANIEL Lukáš SISÁKOVÁ Alexandra NIKULENKOV Fedor KREJČÍ Lumír

  Patent

  Publisher: IP Australia, state: Australia, patent's number: AU2019256670, year: 2022

• Substituted propanamides as inhibitors of nucleases

  PARUCH Kamil CARBAIN Benoit Jean-Pierre HAVEL Štěpán VŠIANSKÝ Vít NIKULENKOV Fedor KREJČÍ Lumír

  Patent

  Publisher: United States Patent and Trademark Office, state: United States of America, patent's number: US11453663, year: 2022

• Substituted propanamides as inhibitors of nucleases

  PARUCH Kamil CARBAIN Benoit Jean-Pierre HAVEL Štěpán VŠIANSKÝ Vít NIKULENKOV Fedor KREJČÍ Lumír

  Patent

  Publisher: IP Australia, state: Australia, patent's number: AU2019256672, year: 2022

• Synthesis and Profiling of Highly Selective Inhibitors of Methyltransferase DOT1L Based on Carbocyclic C-Nucleosides

  KHIRSARIYA PrashantKumar POSPÍŠIL Patrik MAIER Lukáš BOUDNÝ Miroslav BABÁŠ Martin KROUTIL Ondřej MRÁZ Marek VÁCHA Robert PARUCH Kamil

  Article in Periodical

  Journal of Medicinal Chemistry, year: 2022, volume: 65, edition: 7, DOI

• ヌクレアーゼの阻害剤としての置換アミノチアゾール

  PARUCH Kamil CARBAIN Benoit Jean-Pierre HAVEL Štěpán DAMBORSKÝ Jiří BREZOVSKÝ Jan DANIEL Lukáš SISÁKOVÁ Alexandra NIKULENKOV Fedor KREJČÍ Lumír

  Patent

  Publisher: Japan Patent Office (JPO), state: Japan, patent's number: JP7175031, year: 2022

• ヌクレアーゼの阻害剤としての置換プロパンアミド

  PARUCH Kamil CARBAIN Benoit Jean-Pierre HAVEL Štěpán VŠIANSKÝ Vít NIKULENKOV Fedor KREJČÍ Lumír

  Patent

  Publisher: Japan Patent office, state: Japan, patent's number: JP7148999, year: 2022

• 백혈병, 림프종 및 고형 종양의 치료에 사용하기 위한 4-(1H-이미다졸-5-일)-1H-피롤로[2,3-b]피리딘

  BRYJA Vítězslav JANOVSKÁ Pavlína GREGOROVÁ Michaela NĚMEC Václav KHIRSARIYA PrashantKumar PARUCH Kamil

  Patent

  Publisher: Korean Intellectual Property Office, state: Korea, Republic of, patent's number: KR10-2465111, year: 2022

• 白血病、リンパ腫および固形腫瘍の治療に使用するための４－（１Ｈ－イミダゾール－５－イル）－１Ｈ－ピロロ［２，３－ｂ］ピリジン

  BRYJA Vítězslav JANOVSKÁ Pavlína GREGOROVÁ Michaela NĚMEC Václav KHIRSARIYA PrashantKumar PARUCH Kamil

  Patent

  Publisher: Japan Patent Office, state: Japan, patent's number: JP7008967, year: 2022